Skip to main content
. 2016 Oct 4;7:171. doi: 10.3389/fgene.2016.00171

FIGURE 6.

FIGURE 6

Reversal of NF-κBp65 DNA binding activity levels associated with DNP/2DG treatment by autophagy inhibitors. Reversal in NF-κBp65 DNA binding activity following treatment with autophagy inhibitors 3-methyladenine (3-MA), chloroquine (CQ), and Bafilomycin-A1 (Baf). Means and standard deviations of three independent experiments are provided. For all inhibitors, NF-κBp65 DNA binding activity is significantly reduced if compared to the DNP/2DG treated sample (t-test, p < 0.005).

HHS Vulnerability Disclosure